Back to top
more

Amedisys (AMED)

(Delayed Data from NSDQ)

$96.80 USD

96.80
467,848

-0.91 (-0.93%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $96.80 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 23% (58 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Zacks News

Centene's Fidelis Care Buyout to Expand Presence in New York

Centene's (CNC) acquisition of Fidelis Care for $3.75 billion for expanding in New York, is expected to impact Centene's top line and bottom line positively.

    5 Discounted MedTech Stocks for a Healthy Portfolio

    In view of the current political scenario and banking on favorable metrics, these five MedTech stocks stand out as the most suitable value picks.

      Universal Health (UHS) Grows on Buyouts, Expenses a Drag

      Despite solid revenue growth backed by inorganic strategies, Universal Health's (UHS) rising level of debt and expenses continue to weigh on margins.

        Top Ranked Growth Stocks to Buy for September 11th

        Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 11th:

          Amedisys to Buy Intercity Home Care, Boosts Personal Care Arm

          Amedisys (AMED) to strengthen its position in Personal Care business in Massachusetts with this recently signed acquisition deal.

            3 Excellent Value Picks as Political Chaos Grips MedTech

            In view of the current political scenario and banking on favorable metrics, these three MedTech stocks stand out as the most suitable value picks.

              Ensign Group's Inorganic Growth Impresses, Debt Level Hurts

              Ensign Group's (ENSG) top line rises on inorganic and organic growth. Its financial health also impresses. However high level of costs and debts bother.

                Molina Healthcare's Top Line Grows on Membership, Debts Hurt

                Molina Healthcare's (MOH) top line benefits from inorganic growth and membership. However, rising level of debt and expenses hurt margins.

                  WellCare Health Partners Mission Health to Improve Offerings

                  WellCare Health Plans, Inc's (WCG) subsidiary, Wellcare of North Carolina recently entered into an agreement with Mission Health to provide better Medicaid and Medicare services in North Carolina.

                    Centene (CNC) Poised to Grow on Buyouts, High Debt Bothers

                    Centene's (CNC) accretive acquisitions backed by solid financials add to its top line. However, high debt and rising expenses hurt margins.

                      Amedisys (AMED) Up 3.6% Since Earnings Report: Can It Continue?

                      Amedisys (AMED) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

                        Here's Why Chemed (CHE) is a Suitable Growth Pick for Now

                        Banking on favorable Net Margin and ROE, Chemed (CHE) stands out as one of the most suitable growth stocks.

                          IDEXX Laboratories (IDXX), Great Growth Pick: Here's Why

                          Banking on a number of favorable metrics, IDEXX Laboratories (IDXX) stands out as one of the most suitable growth stock.

                            Is Amedisys (AMED) a Great Value Stock for Your Portfolio?

                            Banking on a number of favorable metrics, Amedisys (AMED) stands out as one of the most suitable value stock.

                              Here's Why Masimo (MASI) is a Suitable Value Pick for Now

                              Masimo (MASI) seems to be a solid value pick with favorable P/E ratio and P/FCF ratio compared with its broader industry.

                                Here's Why Investors Should Buy Amedisys (AMED) Right Now

                                Strength in Hospice and Personal Care businesses offset the weakness in Amedisys' (AMED) Home Health Medicare business.

                                  Tabula Rasa Healthcare (TRHC) Catches Eye: Stock Up 9.5%

                                  Tabula Rasa Healthcare, Inc. (TRHC) shares rose around 10% in the last trading session.

                                    Aetna's (AET) $1 Billion Notes Due 2047 Rated By A.M Best

                                    Rating Giant A.M Bests assigned a Long-Term Issue Credit Rating of "bbb" to Aetna's (AET) $1 billion, 3.875% senior notes due to mature on Aug 15, 2047.

                                      Envision Healthcare Hurt by High Debt, Increasing Expenses

                                      Envision Healthcare's (EVHC) increasing debt and expenses continue to hurt. Further guidance cut by the company is concerning.

                                        Amedisys (AMED) Earnings & Revenues Miss Estimates in Q2

                                        Strength in Hospice and Personal Care businesses offset the weakness in Amedisys' (AMED) Home Health Medicare business in Q2.

                                          Community Health Sells 2 Texas Units, Streamlines Business

                                          Community Health Systems, Inc.'s (CYH) subsidiaries have sold their ownership interest in two Texas hospitals and their associated assets to subsidiaries of HCA Healthcare.

                                            Amedisys (AMED) Prospects Impressive Amid Tough Competition

                                            On Jun 5, we issued an updated research report on leading molecular diagnostic company, Amedisys, Inc. (AMED).

                                              Why Is Amedisys (AMED) Up 4% Since the Last Earnings Report?

                                              Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                                Amedisys (AMED) Beats on Q1 Earnings, Revenues Meet Mark

                                                Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 47 cents per share in the first quarter of 2017, up 42.4% year over year.

                                                  Healthcare Q1 Earnings Slated on May 2: AET, HCA & More

                                                  The healthcare sector has been in the limelight since the change of power at the White House.